Money

At least two drugmakers say they’re feeling the impact of the Inflation Reduction Act, after the first drug pr…

Bristol Myers Squibb’s growth portfolio is offsetting declines in older products as planned, even as star hear…

The therapy is part of a plan to develop gene therapies that can be efficiently delivered at lower doses, enab…

The company is making up for a decline in U.S. vaccine sales with better results elsewhere, continuing a turna…

A trio of biotechs priced their IPOs on Thursday into Friday morning, setting the stage for their public tradi…